Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
9.51
+0.48 (5.32%)
At close: May 12, 2025, 4:00 PM
9.84
+0.33 (3.51%)
After-hours: May 12, 2025, 6:19 PM EDT
Adaptive Biotechnologies (ADPT) Revenue by Segment
History
| Date | MRD | Immune Medicine |
|---|---|---|
| Mar 31, 2025 | 156.62M | 32.90M |
| Dec 31, 2024 | 145.53M | 33.43M |
| Sep 30, 2024 | 136.14M | 41.14M |
| Jun 30, 2024 | 123.34M | 45.43M |
| Mar 31, 2024 | 113.94M | 60.56M |
| Dec 31, 2023 | 102.74M | 67.54M |
| Sep 30, 2023 | 100.08M | 79.61M |
| Jun 30, 2023 | 95.37M | 94.23M |
| Mar 31, 2023 | 90.77M | 93.57M |
| Dec 31, 2022 | 87.14M | 98.16M |
| Sep 30, 2022 | 75.59M | 92.45M |
| Jun 30, 2022 | 71.49M | 88.18M |
| Mar 31, 2022 | 65.68M | 88.84M |
| Dec 31, 2021 | 66.21M | 88.13M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.